SQM(SQM) - 2022 Q4 - Annual Report

Report of Foreign Private Issuer (Form 6-K) This report outlines the filing of Form 20-F for FY2022, covering company details and administrative contacts Filing of Annual Report (Form 20-F) SQM filed its Annual Report on Form 20-F for FY2022 with the SEC, making it publicly accessible online - SQM has filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2022, with the SEC[3] - The Form 20-F can be accessed on the SEC's website (www.sec.gov) or the investor relations section of the company's website (www.sqm.com)[3](index=3&type=chunk) Company Overview SQM is a dual-listed global company focused on essential industries, aiming for leadership in key chemical markets - SQM is a dual-listed company on the New York Stock Exchange (NYSE: SQM) and the Santiago Stock Exchange (SQM-B, SQM-A)[4] - The company's products serve key industries including health, nutrition, renewable energy, and technology[4] - SQM's strategic goal is to be a world leader in the markets for lithium, potassium nitrate, iodine, and thermo-solar salts[4] Administrative Information This section provides contact details for investor relations and media, formally signed by the CFO on April 25, 2023 - The document lists specific contacts for investor relations and media inquiries[5] - The report was duly authorized and signed by Gerardo Illanes, CFO, on April 25, 2023[7]